Literature DB >> 20408820

Circulating tumor cells and biomarkers: implications for personalized targeted treatments for metastatic breast cancer.

James M Reuben, Bang-Ning Lee, Changping Li, Hui Gao, Kristine R Broglio, Vicente Valero, Summer A Jackson, Naoto T Ueno, Savitri Krishnamurthy, Gabriel N Hortobagyi, Massimo Cristofanilli.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20408820     DOI： 10.1111/j.1524-4741.2010.00910.x

Source DB:  PubMed          Journal:  Breast J        ISSN： 1075-122X            Impact factor:   2.431


× No keyword cloud information.
  9 in total

1.  Multiple biomarker expression on circulating tumor cells in comparison to tumor tissues from primary and metastatic sites in patients with locally advanced/inflammatory, and stage IV breast cancer, using a novel detection technology.

Authors:  George Somlo; Sean K Lau; Paul Frankel; H Ben Hsieh; Xiaohe Liu; Lixin Yang; Robert Krivacic; Richard H Bruce
Journal:  Breast Cancer Res Treat       Date:  2011-04-16       Impact factor: 4.872

Review 2.  Circulating tumour cells and cell-free DNA as tools for managing breast cancer.

Authors:  Leticia De Mattos-Arruda; Javier Cortes; Libero Santarpia; Ana Vivancos; Josep Tabernero; Jorge S Reis-Filho; Joan Seoane
Journal:  Nat Rev Clin Oncol       Date:  2013-05-28       Impact factor: 66.675

3.  Inflammation-based indexes and clinicopathologic features are strong predictive values of preoperative circulating tumor cell detection in gastric cancer patients.

Authors:  L Zheng; K Zou; C Yang; F Chen; T Guo; B Xiong
Journal:  Clin Transl Oncol       Date:  2017-03-17       Impact factor: 3.405

4.  Epithelial-mesenchymal transition and stem cell markers in patients with HER2-positive metastatic breast cancer.

Authors:  Antonio Giordano; Hui Gao; Simone Anfossi; Evan Cohen; Michal Mego; Bang-Ning Lee; Sanda Tin; Michele De Laurentiis; Charla A Parker; Ricardo H Alvarez; Vicente Valero; Naoto T Ueno; Sabino De Placido; Sendurai A Mani; Francisco J Esteva; Massimo Cristofanilli; James M Reuben
Journal:  Mol Cancer Ther       Date:  2012-09-12       Impact factor: 6.261

5.  Phase Ib Pilot Study to Evaluate Reparixin in Combination with Weekly Paclitaxel in Patients with HER-2-Negative Metastatic Breast Cancer.

Authors:  Anne F Schott; Lori J Goldstein; Massimo Cristofanilli; Pier Adelchi Ruffini; Susan McCanna; James M Reuben; Raymond P Perez; Giraldo Kato; Max Wicha
Journal:  Clin Cancer Res       Date:  2017-05-24       Impact factor: 12.531

Review 6.  Molecular mechanisms of metastasis in breast cancer--clinical applications.

Authors:  Michal Mego; Sendurai A Mani; Massimo Cristofanilli
Journal:  Nat Rev Clin Oncol       Date:  2010-10-19       Impact factor: 66.675

7.  Circulating tumor cells as prognostic and predictive markers in metastatic breast cancer patients receiving first-line systemic treatment.

Authors:  Mario Giuliano; Antonio Giordano; Summer Jackson; Kenneth R Hess; Ugo De Giorgi; Michal Mego; Beverly C Handy; Naoto T Ueno; Ricardo H Alvarez; Michelino De Laurentiis; Sabino De Placido; Vicente Valero; Gabriel N Hortobagyi; James M Reuben; Massimo Cristofanilli
Journal:  Breast Cancer Res       Date:  2011-06-15       Impact factor: 6.466

8.  Circulating tumor cells in newly diagnosed inflammatory breast cancer.

Authors:  Michal Mego; Antonio Giordano; Ugo De Giorgi; Hiroko Masuda; Limin Hsu; Mario Giuliano; Tamer M Fouad; Shaheenah Dawood; Naoto T Ueno; Vicente Valero; Eleni Andreopoulou; Ricardo H Alvarez; Wendy A Woodward; Gabriel N Hortobagyi; Massimo Cristofanilli; James M Reuben
Journal:  Breast Cancer Res       Date:  2015-01-09       Impact factor: 6.466

9.  Feasibility of a novel one-stop ISET device to capture CTCs and its clinical application.

Authors:  Fangfang Chen; Shuyi Wang; Yuan Fang; Liang Zheng; Xuan Zhi; Boran Cheng; Yuanyuan Chen; Chunxiao Zhang; Dongdong Shi; Haibin Song; Congli Cai; Pengfei Zhou; Bin Xiong
Journal:  Oncotarget       Date:  2017-01-10
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.